Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro - PubMed (original) (raw)
Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro
J R Grandis et al. J Clin Invest. 1998.
Abstract
Stimulation of epidermal growth factor receptor (EGFR) by ligand(s) leads to activation of signaling molecules including Stat1 and Stat3, two members of the signal transducers and activators of transcription (STAT) protein family. Activation of Stat1 and Stat3 was constitutive in transformed squamous epithelial cells, which produce elevated levels of TGF-alpha, and was enhanced by the addition of exogenous TGF-alpha. Targeting of Stat3 using antisense oligonucleotides directed against the translation initiation site, resulted in significant growth inhibition. In addition, cells stably transfected with dominant negative mutant Stat3 constructs failed to proliferate in vitro. In contrast, targeting of Stat1 using either antisense or dominant-negative strategies had no effect on cell growth. Thus, TGF-alpha/EGFR-mediated autocrine growth of transformed epithelial cells is dependent on activation of Stat3 but not Stat1.
Similar articles
- Differential function of STAT5 isoforms in head and neck cancer growth control.
Leong PL, Xi S, Drenning SD, Dyer KF, Wentzel AL, Lerner EC, Smithgall TE, Grandis JR. Leong PL, et al. Oncogene. 2002 Apr 25;21(18):2846-53. doi: 10.1038/sj.onc.1205385. Oncogene. 2002. PMID: 11973644 - STAT signaling in head and neck cancer.
Song JI, Grandis JR. Song JI, et al. Oncogene. 2000 May 15;19(21):2489-95. doi: 10.1038/sj.onc.1203483. Oncogene. 2000. PMID: 10851047 Review. - STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo.
Kijima T, Niwa H, Steinman RA, Drenning SD, Gooding WE, Wentzel AL, Xi S, Grandis JR. Kijima T, et al. Cell Growth Differ. 2002 Aug;13(8):355-62. Cell Growth Differ. 2002. PMID: 12193474 - The role of STATs in transcriptional control and their impact on cellular function.
Bromberg J, Darnell JE Jr. Bromberg J, et al. Oncogene. 2000 May 15;19(21):2468-73. doi: 10.1038/sj.onc.1203476. Oncogene. 2000. PMID: 10851045 Review.
Cited by
- Delineating the role of nuclear receptors in colorectal cancer, a focused review.
Manickasamy MK, Jayaprakash S, Girisa S, Kumar A, Lam HY, Okina E, Eng H, Alqahtani MS, Abbas M, Sethi G, Kumar AP, Kunnumakkara AB. Manickasamy MK, et al. Discov Oncol. 2024 Feb 19;15(1):41. doi: 10.1007/s12672-023-00808-x. Discov Oncol. 2024. PMID: 38372868 Free PMC article. Review. - Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics.
Adesoye T, Tripathy D, Hunt KK, Keyomarsi K. Adesoye T, et al. Cancers (Basel). 2024 Jan 24;16(3):492. doi: 10.3390/cancers16030492. Cancers (Basel). 2024. PMID: 38339245 Free PMC article. Review. - Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer-Drug Carriers Matter.
Molenda S, Sikorska A, Florczak A, Lorenc P, Dams-Kozlowska H. Molenda S, et al. Cancers (Basel). 2023 Nov 29;15(23):5647. doi: 10.3390/cancers15235647. Cancers (Basel). 2023. PMID: 38067351 Free PMC article. Review. - Exploring the recent trends in perturbing the cellular signaling pathways in cancer by natural products.
Rahman MM, Sarker MT, Alam Tumpa MA, Yamin M, Islam T, Park MN, Islam MR, Rauf A, Sharma R, Cavalu S, Kim B. Rahman MM, et al. Front Pharmacol. 2022 Sep 8;13:950109. doi: 10.3389/fphar.2022.950109. eCollection 2022. Front Pharmacol. 2022. PMID: 36160435 Free PMC article. Review. - The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer.
Khatoon E, Hegde M, Kumar A, Daimary UD, Sethi G, Bishayee A, Kunnumakkara AB. Khatoon E, et al. Arch Pharm Res. 2022 Aug;45(8):507-534. doi: 10.1007/s12272-022-01398-y. Epub 2022 Aug 20. Arch Pharm Res. 2022. PMID: 35987863 Review.
References
- Carcinogenesis. 1989 Aug;10(8):1553-6 - PubMed
- J Natl Cancer Inst. 1998 Jun 3;90(11):824-32 - PubMed
- Cell. 1990 Apr 20;61(2):203-12 - PubMed
- Cancer Res. 1990 May 15;50(10):3113-8 - PubMed
- EMBO J. 1990 Dec;9(13):4477-84 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous